GT Medical Technologies, Inc., a medical device company dedicated to improving the lives of patients with brain tumors, has announced that it has raised US$45 million in a Series C financing led by Gilde Healthcare Partners with participation from existing institutional investors MVM Partners, MedTech Venture Partners, and BlueStone Venture Partners.
Latham & Watkins LLP represented GT Medical Technologies in the financing with a corporate team led by Bay Area partner Luke Bergstrom, with associates Omar Ammash, Erica Kucharski, Autumn Schmidt, and Jude Baldo. Advice was also provided on tax and benefits & compensation matters by Bay Area partner Ashley Wagner.
